BRIEF published on 07/30/2024 at 17:50, 3 months 21 days ago Airbus Reports Half-Year 2024 Financial Results Cash Flow EBIT Adjusted Commercial Aircraft Deliveries H1 2024 Earnings Airbus Financial Results
PRESS RELEASE published on 07/30/2024 at 17:45, 3 months 21 days ago EQS-Adhoc: Airbus reports Half-Year (H1) 2024 results Airbus reports Half-Year (H1) 2024 results including €28.8 billion revenues and €1.4 billion adjusted EBIT, addressing challenges in space business and aircraft deliveries Revenues Airbus Half-year Results Commercial Aircraft EBIT Adjusted
BRIEF published on 06/24/2024 at 19:10, 4 months 26 days ago Airbus Updates 2024 Guidance Amid Space and Supply Chain Challenges 2024 Guidance Airbus Supply Chain Commercial Aircraft
PRESS RELEASE published on 06/24/2024 at 19:05, 4 months 26 days ago EQS-Adhoc: Airbus provides 2024 guidance update Airbus provides 2024 guidance update, includes €0.9bn charges for space programs. 770 commercial aircraft deliveries expected in 2024. Analyst call scheduled. Half-year results on July 30 Airbus Commercial Aircraft Deliveries 2024 Guidance Update Space Programs Analyst Call
BRIEF published on 04/25/2024 at 17:50, 6 months 25 days ago Airbus Reports First Quarter 2024 Financial Performance Financial Performance Airbus Q1 Results Production Rate Increase EBIT Adjusted Commercial Aircraft Deliveries
PRESS RELEASE published on 04/25/2024 at 17:45, 6 months 25 days ago EQS-Adhoc: Airbus reports First Quarter (Q1) 2024 results Airbus SE reports First Quarter (Q1) 2024 results, including 142 commercial aircraft delivered and revenues of €12.8 billion. EBIT Adjusted at €0.6 billion with unchanged 2024 guidance Revenues First Quarter Results Airbus SE Commercial Aircraft Q1 2024
PRESS RELEASE published on 02/15/2024 at 06:30, 9 months 6 days ago EQS-Adhoc: Airbus reports Full-Year (FY) 2023 results Airbus SE reports Full-Year (FY) 2023 results including 735 commercial aircraft delivered and revenues of €65.4 billion. The company achieved 2023 guidance and issues 2024 guidance Revenues Financial Results Airbus SE Full-Year 2023 Commercial Aircraft
PRESS RELEASE published on 11/08/2023 at 17:45, 1 year ago EQS-Adhoc: Airbus reports Nine-Month (9m) 2023 results
PRESS RELEASE published on 07/26/2023 at 17:45, 1 year 3 months ago EQS-Adhoc: Airbus reports Half-Year (H1) 2023 results
PRESS RELEASE published on 05/03/2023 at 17:45, 1 year 6 months ago EQS-Adhoc: Airbus reports First Quarter (Q1) 2023 results
Published on 11/21/2024 at 13:00, 38 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 38 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 38 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 38 minutes ago Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Published on 11/21/2024 at 13:00, 38 minutes ago Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension
Published on 11/21/2024 at 12:35, 1 hour 3 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 23 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 40 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 18 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 19 hours 53 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 19 hours 53 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 5 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
